155 related articles for article (PubMed ID: 32589926)
1. A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.
Nagpal S; Braner S; Modh H; Tan AXX; Mast MP; Chichakly K; Albrecht V; Wacker MG
Eur J Pharm Biopharm; 2020 Aug; 153():257-272. PubMed ID: 32589926
[TBL] [Abstract][Full Text] [Related]
2. Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations.
Luo R; Li Y; He M; Zhang H; Yuan H; Johnson M; Palmisano M; Zhou S; Sun D
Int J Pharm; 2017 Mar; 519(1-2):1-10. PubMed ID: 28063903
[TBL] [Abstract][Full Text] [Related]
3. Predicting human pharmacokinetics of liposomal temoporfin using a hybrid in silico model.
Jablonka L; Ashtikar M; Gao GF; Thurn M; Modh H; Wang JW; Preuß A; Scheglmann D; Albrecht V; Röder B; Wacker MG
Eur J Pharm Biopharm; 2020 Apr; 149():121-134. PubMed ID: 32035970
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with Doxorubicin.
Kovshova T; Osipova N; Alekseeva A; Malinovskaya J; Belov A; Budko A; Pavlova G; Maksimenko O; Nagpal S; Braner S; Modh H; Balabanyan V; Wacker MG; Gelperina S
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562687
[TBL] [Abstract][Full Text] [Related]
5. Electrosprayed Myocet-like Liposomes: An Alternative to Traditional Liposome Production.
Collier MA; Bachelder EM; Ainslie KM
Pharm Res; 2017 Feb; 34(2):419-426. PubMed ID: 27896588
[TBL] [Abstract][Full Text] [Related]
6. Rapid Analysis of DOXIL Stability and Drug Release from DOXIL by HPLC Using a Glycidyl Methacrylate-Coated Monolithic Column.
Kimoto A; Watanabe A; Yamamoto E; Higashi T; Kato M
Chem Pharm Bull (Tokyo); 2017; 65(10):945-949. PubMed ID: 28966279
[TBL] [Abstract][Full Text] [Related]
7. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
[TBL] [Abstract][Full Text] [Related]
8. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
[TBL] [Abstract][Full Text] [Related]
10. Injectable drug delivery systems of doxorubicin revisited: In vitro-in vivo relationships using human clinical data.
Modh H; Fang DJ; Ou YH; Yau JNN; Kovshova T; Nagpal S; Knoll J; Wallenwein CM; Maiti K; Bhowmick S; Gelperina S; Pastorin G; Wacker MG
Int J Pharm; 2021 Oct; 608():121073. PubMed ID: 34481887
[TBL] [Abstract][Full Text] [Related]
11. In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site.
Silverman L; Barenholz Y
Nanomedicine; 2015 Oct; 11(7):1841-50. PubMed ID: 26115641
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency-Triggered Drug Release from Nanoliposomes with Millimeter-Scale Resolution Using a Superimposed Static Gating Field.
Liu JF; Neel N; Dang P; Lamb M; McKenna J; Rodgers L; Litt B; Cheng Z; Tsourkas A; Issadore D
Small; 2018 Nov; 14(44):e1802563. PubMed ID: 30286280
[TBL] [Abstract][Full Text] [Related]
13. Predicting drug release kinetics from nanocarriers inside dialysis bags.
Yu M; Yuan W; Li D; Schwendeman A; Schwendeman SP
J Control Release; 2019 Dec; 315():23-30. PubMed ID: 31629038
[TBL] [Abstract][Full Text] [Related]
14. Development of a flow-through USP 4 apparatus drug release assay for the evaluation of amphotericin B liposome.
Tang J; Srinivasan S; Yuan W; Ming R; Liu Y; Dai Z; Noble CO; Hayes ME; Zheng N; Jiang W; Szoka FC; Schwendeman A
Eur J Pharm Biopharm; 2019 Jan; 134():107-116. PubMed ID: 30481559
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
16. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
17. Influence of the method of preparation on the characteristics and performance of cholesterol-based polymeric nanoparticles for redox-triggered release of doxorubicin in tumor cells.
Gonzalez-Fajardo L; Ndaya D; Kasi RM; Lu X
Int J Pharm; 2019 Nov; 571():118701. PubMed ID: 31593806
[TBL] [Abstract][Full Text] [Related]
18. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
Cattel L; Ceruti M; Dosio F
J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
[TBL] [Abstract][Full Text] [Related]
19. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
20. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
